Eugene S Kandel Selected Research

Cyclic AMP-Dependent Protein Kinase Type II

1/2014

Protein kinase A type II-α regulatory subunit regulates the response of prostate cancer cells to taxane treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eugene S Kandel Research Topics

Disease

16	Neoplasms (Cancer) 10/2021 - 11/2002
3	Melanoma (Melanoma, Malignant) 01/2020 - 01/2018
2	Neoplasm Metastasis (Metastasis) 01/2019 - 01/2018
2	Prostatic Neoplasms (Prostate Cancer) 01/2014 - 05/2011
1	Hyperplasia 01/2019
1	Acute Kidney Injury (Acute Renal Failure) 01/2019
1	Ischemia 01/2019
1	Leprosy (Hansen's Disease) 10/2018
1	Multiple Myeloma 10/2018
1	Carcinoma (Carcinomatosis) 01/2018
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 03/2014
1	Mouth Neoplasms (Oral Cancer) 07/2012
1	Infections 09/2009
1	Coinfection 09/2008
1	Carcinogenesis 04/2008
1	Inflammation (Inflammations) 03/2006

Drug/Important Bio-Agent (IBA)

3	MicroRNAs (MicroRNA)IBA 05/2013 - 03/2006
2	Transcription Factors (Transcription Factor)IBA 01/2018 - 12/2013
2	Messenger RNA (mRNA)IBA 12/2013 - 04/2008
2	DNA (Deoxyribonucleic Acid)IBA 01/2012 - 05/2011
2	AndrogensIBA 01/2012 - 05/2011
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 10/2021
1	Mitogen-Activated Protein KinasesIBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019
1	AntioxidantsIBA 01/2019
1	Cysteine (L-Cysteine)FDA Link 01/2019
1	Oxygen (Dioxygen)IBA 01/2019
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 10/2018
1	Clofazimine (Lamprene)FDA Link 10/2018
1	Pharmaceutical PreparationsIBA 10/2018
1	PolyaminesIBA 10/2018
1	Cadherins (E-Cadherin)IBA 01/2018
1	p21-Activated KinasesIBA 01/2017
1	Bleomycin (Blenoxane)FDA LinkGeneric 03/2014
1	AmidesIBA 01/2014
1	taxaneIBA 01/2014
1	Docetaxel (Taxotere)FDA Link 01/2014
1	Hormones (Hormone)IBA 01/2014
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 01/2014
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2014
1	Cyclic AMP-Dependent Protein Kinase Type IIIBA 01/2014
1	Tumor Suppressor Protein p14ARF (p14ARF)IBA 12/2013
1	Protein Kinases (Protein Kinase)IBA 07/2012
1	Indicators and Reagents (Reagents)IBA 07/2012
1	Biomarkers (Surrogate Marker)IBA 07/2012
1	Mitochondrial DNA (mtDNA)IBA 07/2012
1	AllergensIBA 07/2010
1	GTP-Binding Proteins (G-Protein)IBA 09/2009
1	Complement System Proteins (Complement)IBA 09/2008
1	RNA (Ribonucleic Acid)IBA 03/2006
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 11/2002

Therapy/Procedure

3	Therapeutics 10/2018 - 01/2014